Sign in to view content

Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

Andrew J. Barkmeier, MD

Video
Published 2024

Related

Diabetic Retinopathy 1 Symposium
Annual Meeting Talks
2020
Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial
Susan B. Bressler, MD, FASRS
Updates from the Field
2017
Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread Protocol
Andrew J. Barkmeier, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more